2023 Q2 Form 10-Q Financial Statement

#000149315223017261 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $480.00
YoY Change -89.24%
Cost Of Revenue $9.860K
YoY Change -57.11%
Gross Profit -$9.380K
YoY Change -49.38%
Gross Profit Margin -1954.17%
Selling, General & Admin $4.860M $3.450M $827.3K
YoY Change 401.62% 317.01% -25.62%
% of Gross Profit
Research & Development $4.660M $1.030M
YoY Change
% of Gross Profit
Depreciation & Amortization $4.093K $4.015K $7.570K
YoY Change -70.04% -46.96% -37.39%
% of Gross Profit
Operating Expenses $9.524M $4.479M $827.3K
YoY Change 862.69% 441.44% -25.62%
Operating Profit -$9.524M -$4.479M -$836.7K
YoY Change 839.91% 435.37% -26.01%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$126.9K -$14.02K $1.950K
YoY Change 906300.0% -818.72% 828.57%
Pretax Income -$9.397M -$4.465M -$834.7K
YoY Change 827.4% 434.94% -30.17%
Income Tax
% Of Pretax Income
Net Earnings -$9.127M -$3.966M -$531.5K
YoY Change 947.82% 646.19% -25.77%
Net Earnings / Revenue -110727.08%
Basic Earnings Per Share -$1.02 -$0.60
Diluted Earnings Per Share -$1.02 -$0.60 -$166.50
COMMON SHARES
Basic Shares Outstanding 9.706M shares 6.738M shares 4.256M shares
Diluted Shares Outstanding 8.966M shares 6.635M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.17M $4.990M $54.23K
YoY Change 5021.11% 9101.55% -79.32%
Cash & Equivalents $20.17M $4.988M $54.23K
Short-Term Investments
Other Short-Term Assets $70.00K $50.00K $26.83K
YoY Change 214.75% 86.36% 2233.04%
Inventory
Prepaid Expenses
Receivables $99.00 $94.00 $230.00
Other Receivables $20.00K $20.00K $19.46K
Total Short-Term Assets $20.25M $5.056M $100.7K
YoY Change 4565.25% 4918.78% -66.36%
LONG-TERM ASSETS
Property, Plant & Equipment $365.9K $219.3K $76.73K
YoY Change 443.65% 185.84% 9.54%
Goodwill
YoY Change
Intangibles $7.361M $6.961M
YoY Change 387.88%
Long-Term Investments $150.0K $150.0K $150.0K
YoY Change 0.0% 0.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $7.877M $7.331M $1.760M
YoY Change 356.35% 316.41% 17.69%
TOTAL ASSETS
Total Short-Term Assets $20.25M $5.056M $100.7K
Total Long-Term Assets $7.877M $7.331M $1.760M
Total Assets $28.13M $12.39M $1.861M
YoY Change 1202.14% 565.52% 3.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.970M $630.0K $360.0K
YoY Change 479.41% 75.0% -68.97%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $3.612M $2.459M $923.7K
YoY Change 326.3% 166.22% -64.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $52.58K $76.29K $129.9K
YoY Change -54.44% -41.27% 17.78%
Total Long-Term Liabilities $52.58K $76.29K $129.9K
YoY Change -54.44% -41.27% 17.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.612M $2.459M $923.7K
Total Long-Term Liabilities $52.58K $76.29K $129.9K
Total Liabilities $23.66M $2.535M $2.449M
YoY Change 2358.32% 3.54% -44.71%
SHAREHOLDERS EQUITY
Retained Earnings -$72.68M -$63.55M
YoY Change 28.95%
Common Stock $10.03K $6.739K
YoY Change -99.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.122M $9.240M -$587.5K
YoY Change
Total Liabilities & Shareholders Equity $28.13M $12.39M $1.861M
YoY Change 1202.14% 565.52% 3.67%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$9.127M -$3.966M -$531.5K
YoY Change 947.82% 646.19% -25.77%
Depreciation, Depletion And Amortization $4.093K $4.015K $7.570K
YoY Change -70.04% -46.96% -37.39%
Cash From Operating Activities $15.44M -$3.663M -$506.1K
YoY Change -1980.11% 623.9% -203.55%
INVESTING ACTIVITIES
Capital Expenditures $1.400M $1.280M -$153.0K
YoY Change -1586.83% -936.6% -83.72%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.400M -$1.276M -$153.0K
YoY Change 1386.83% 733.97% -83.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.120M $9.564M 623.0K
YoY Change -13.04% 1435.21% 33.62%
NET CHANGE
Cash From Operating Activities 15.44M -$3.663M -506.1K
Cash From Investing Activities -1.400M -$1.276M -153.0K
Cash From Financing Activities 1.120M $9.564M 623.0K
Net Change In Cash 15.16M $4.707M -36.07K
YoY Change 3969.03% -13150.25% -339.99%
FREE CASH FLOW
Cash From Operating Activities $15.44M -$3.663M -$506.1K
Capital Expenditures $1.400M $1.280M -$153.0K
Free Cash Flow $14.04M -$4.943M -$353.1K
YoY Change -2031.04% 1300.13% -124.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001540684
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Revenues
Revenues
usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
usd
CY2022Q1 us-gaap Exploration Expense
ExplorationExpense
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 ATLX Issuance Of Sale Of Apollo Resources Common Stock In Connection With Equity Offerings
IssuanceOfSaleOfApolloResourcesCommonStockInConnectionWithEquityOfferings
usd
CY2022Q1 ATLX Payments For Purchase Intangible Assets
PaymentsForPurchaseIntangibleAssets
usd
CY2022Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41552
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ATLAS LITHIUM CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-2078861
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Rua Bahia
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
2463 - Suite 205
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Belo Horizonte
CY2023Q1 dei Entity Address Country
EntityAddressCountry
BR
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30.160-012
CY2023Q1 dei City Area Code
CityAreaCode
+55
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
31-3956-1109
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
ATLX
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9706126 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4987751 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
280525 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
91 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
18243 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
17705 usd
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
49829 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
47093 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
5055917 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
345414 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
219325 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217550 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6961449 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4971267 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
150000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
150000 usd
CY2023Q1 us-gaap Assets
Assets
12386691 usd
CY2022Q4 us-gaap Assets
Assets
5684231 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2437420 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2776474 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2458974 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2797967 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76285 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
78964 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2535259 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2876931 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6728062 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6728062 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5110014 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5110014 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
6739 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5111 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73699668 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62258116 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-915224 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-981040 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63551887 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59585949 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9239511 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1696453 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
611921 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1110847 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9851432 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2807300 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12386691 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5684231 usd
CY2022Q1 us-gaap Revenues
Revenues
477 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
9855 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
-9378 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
141900 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
119841 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1295963 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
221465 usd
CY2023Q1 us-gaap Officers Compensation
OfficersCompensation
883835 usd
CY2022Q1 us-gaap Officers Compensation
OfficersCompensation
97992 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1128845 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
388019 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
1028825 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4479368 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
827317 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4479368 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-836695 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-14015 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1952 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14015 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1952 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4465353 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-834743 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4465353 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-834743 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-499415 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-303253 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3965938 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-531490 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6635325 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4255676 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4465353 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-834743 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
66305 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
56815 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4399048 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-777928 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-498926 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-308741 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3900122 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-469187 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
456866 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
397999 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
196996 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
365546 usd
CY2022Q1 ATLX Issuance Of Sale Of Apollo Resources Common Stock In Connection With Equity Offerings
IssuanceOfSaleOfApolloResourcesCommonStockInConnectionWithEquityOfferings
225000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-834743 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
807664 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2807300 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9489335 usd
CY2023Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
750000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
192012 usd
CY2023Q1 ATLX Exercise Of Warrants
ExerciseOfWarrants
197613 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
739220 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
66305 usd
CY2023Q1 ATLX Issuance Of Jupiter Gold Common Stock In Connection With Sales Made Under Private Offerings
IssuanceOfJupiterGoldCommonStockInConnectionWithSalesMadeUnderPrivateOfferings
75000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4465353 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9851432 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4465353 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-834743 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1128845 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
388019 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4015 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7571 usd
CY2023Q1 ATLX Payments For Purchase Intangible Assets
PaymentsForPurchaseIntangibleAssets
720000 usd
CY2023Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
14015 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1170 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
538 usd
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2948 usd
CY2023Q1 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-2736 usd
CY2022Q1 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-9580 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1058993 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-76519 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2679 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
20959 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3663428 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-506071 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
5790 usd
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
30472 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1270182 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
122526 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1275972 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-152998 usd
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
9489335 usd
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
397999 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
75000 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
225000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9564335 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
622999 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
82290 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67524 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4707226 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
31454 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
280525 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22776 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4987751 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54230 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zNThyTlFQu7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zsUG7aby3hvl">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ATLAS LITHIUM CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – ORGANIZATION, BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
666190 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
446865 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
219325 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
659282 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
441732 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217550 usd
CY2023Q1 us-gaap Depreciation
Depreciation
4015 usd
CY2022Q1 us-gaap Depreciation
Depreciation
7571 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6961449 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4971267 usd
CY2023Q1 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
629379 usd
CY2022Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
408874 usd
CY2023Q1 ATLX Mineral Rights Payable Current And Noncurrent
MineralRightsPayableCurrentAndNoncurrent
1808041 usd
CY2022Q4 ATLX Mineral Rights Payable Current And Noncurrent
MineralRightsPayableCurrentAndNoncurrent
2367600 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2437420 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2776474 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76285 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
78964 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split of our issued and outstanding shares of common stock at a ratio of 1-for-750 (the “Reverse Stock Split”). Following the Reverse Stock Split, each 750 shares of our issued and outstanding shares of common stock were automatically converted into one issued and outstanding share of common stock, without any change in par value per share.
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
2.7206 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.8094 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7900 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.2000 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0342 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0399 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.009 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0183 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
197614 usd
CY2023Q1 us-gaap Payments For Rent
PaymentsForRent
5750 usd
CY2023Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p id="xdx_807_eus-gaap--LossContingencyDisclosures_z7oOi1EujfJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_822_zKZIiXAzTuPl">RISKS AND UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Currency Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We operate primarily in Brazil which exposes us to currency risks. Our business activities may generate intercompany receivables or payables that are in a currency other than the functional currency of the entity. Changes in exchange rates from the time the activity occurs to the time payments are made may result in it receiving either more or less in local currency than the local currency equivalent at the time of the original activity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements are denominated in U.S. dollars. Accordingly, changes in exchange rates between the applicable foreign currency and the U.S. dollar affect the translation of each foreign subsidiary’s financial results into U.S. dollars for purposes of reporting in the consolidated financial statements. Our foreign subsidiaries translate their financial results from the local currency into U.S. dollars in the following manner: (a) income statement accounts are translated at average exchange rates for the period; (b) balance sheet asset and liability accounts are translated at end of period exchange rates; and (c) equity accounts are translated at historical exchange rates. Translation in this manner affects the shareholders’ equity account referred to as the foreign currency translation adjustment account. This account exists only in the foreign subsidiaries’ U.S. dollar balance sheets and is necessary to keep the foreign subsidiaries’ balance sheets in agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>

Files In Submission

Name View Source Status
atlx-20230331_cal.xml Edgar Link unprocessable
atlx-20230331_pre.xml Edgar Link unprocessable
atlx-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001493152-23-017261-index-headers.html Edgar Link pending
0001493152-23-017261-index.html Edgar Link pending
0001493152-23-017261.txt Edgar Link pending
0001493152-23-017261-xbrl.zip Edgar Link pending
atlx-20230331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
atlx-20230331_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending